🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The evidence has been piling up for years now. Lower LDL-C for longer is better for your health! Most guidelines recommend a cholesterol check every five years for healthy adults. Knowing your levels is the first step toward early intervention, if needed.

#Moncyte is hiring a data scientist with broad #Python skills in data and image analysis, and a laboratory technician for processing incoming samples and laboratory organization. linkedin.com/jobs/view/4032… linkedin.com/jobs/view/4032…

A very important milestone in our short company history! MONCYTE Health secured 1 million € seed funding to advance personalized treatment for high #cholesterol! Big thank you to our investors and the people who support us! moncytehealth.com Medicine and Health, University of Helsinki University of Helsinki

Novel approach to measure interactions of #lipoproteins with #monocytes to assess #lipid droplets and cellular functions. Focus on assessment of lipoprotein driven residual risk due #apoB #atherosclerosis #biotech #inflammation

Finnish startup secures €1 million in seed funding for cholesterol treatment research arcticstartup.com/moncyte-health… via @ArcticStartup Inventure Kustaa Piha University of Helsinki Business Finland #funding #nordicmade #Finland #startups #healthtech #deeptech #Trending

#helyes diagnostics company #MONCYTE Health has raised €1M in a seed funding round to advance its technology for treating high cholesterol. By ArcticStartup arcticstartup.com/moncyte-health… #NordicMade #healthtechnordic @AlagirovaT22250 Simon Pfisterer @inventureVC

🎉Thrilled to share our most recent work on how the lipid environment finely regulates the Golgi V-ATPase. A big THANK YOU to everyone in the Ikonen lab IkonenLab @MiesvdStoel X Paul Ph.D 🇫🇮🇺🇦, and our collaborators. 🔬Read more: biorxiv.org/content/10.110…

3 years ago was my first Slush, dreaming of establishing a company. Now back with my amazing co-founder Tamara Alagirova and moncytehealth.com! As always Slush is simply great!

#isa2024 in Oman has been special! Great to meet friends, establish new connections and discuss about moncytehealth.com technology!

My followers dropped by 25% during the past 6 weeks. ➕ Content on this platform is getting increasingly difficult to enjoy. Checking out new options: spfisterer.bsky.social

Exciting news 🚀 MONCYTE Health joins EUR 7 million Horizon Europe funded international consortium for earlier diagnosis and management of Familial Hypercholesterolemia (FH)🔥 Full Press Release here: moncytehealth.com/?p=3908

We wrote an editorial discussing the importance of the conformation of apoB. ApoB-100: The guardian of LDL stability - Atherosclerosis atherosclerosis-journal.com/article/S0021-… This editorial was insipired by an article published earlier in Atherosclerosis atherosclerosis-journal.com/article/S0021-…

Great start of our Horizon Europe project #FHEARLY with an outstanding group of colleagues Faculdade de Medicina ULisboa Lale Tokgozoglu Daccord Magdalena Simon Pfisterer AIDFM-CETERA Dr Meral Kayikcioglu

It has been a great pleasure to write this summary about new developments regarding LDL structure, function and cellular uptake, together with Gilles Lambert! CaixaResearch University of Helsinki HiLIFE_Helsinki #PerMedFH nature.com/articles/s4156…